Who makes Triclosan 0.5 % Topical Solution?

Triclosan 0.5 % Topical Solution is developed by Centro Ortopedico y Quirurgico del Pie.

What development phase is Triclosan 0.5 % Topical Solution in?

Triclosan 0.5 % Topical Solution is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

Triclosan 0.5 % Topical Solution

Centro Ortopedico y Quirurgico del Pie · FDA-approved active Small molecule Quality 3/100

At a glance

Generic name	Triclosan 0.5 % Topical Solution
Also known as	Hand antisepsis with Triclosan 0.5% solution.
Sponsor	Centro Ortopedico y Quirurgico del Pie
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Pre-surgical Antisepsis of Hands After Washing With Triclosan 0.5% Compared to Propan-1-ol 60% (PHASE4)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

Triclosan 0.5 % Topical Solution CI brief — competitive landscape report
Triclosan 0.5 % Topical Solution updates RSS · CI watch RSS
Centro Ortopedico y Quirurgico del Pie portfolio CI